Model for End-Stage Liver Disease (MELD) exception for portal hypertensive gastrointestinal bleeding

Liver Transplantation

Volumn 12, Issue 12 SUPPL. 3, 2006, Pages

  Sheiner, Patricia ^a   Gish, Robert G ^b   Sanyal, Arun ^c  

^a WESTCHESTER MEDICAL CENTER   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE;

ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; CREATININE BLOOD LEVEL; ENDOSCOPIC THERAPY; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER DISEASE; MEDICAL DOCUMENTATION; MORTALITY; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STOMACH VARICES; TREATMENT CONTRAINDICATION;

GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIVER FAILURE; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT;

EID: 33845498120     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1102/lt.20969     Document Type: Article

References (7)

1. Comar KM, Sanyal AJ. Portal hypertensive bleeding. Gastroenterol Clin North Am 2003;32:1079-1105.
2. Tyburski JG, Noorily MJ, Wilson RF. Prognostic factors with the use of the transjugular intrahepatic portosystemic shunt for bleeding varices. Arch Surg 1997;132: 626-630.
3. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-470.
4. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Model for End Stage Liver Disease (MELD) for predicting mortality in patients with acute variceal bleeding. Hepatology 2002;35:1282-1284.
5. Rajan DK, Haskal ZJ, Clark TW. Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis. J Vasc Interv Radiol 2002; 13:155-161.
6. Russo MW, Sood A, Jacobson IM, Brown RS Jr. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality. Am J Gastroenterol 2003;98:2521-2527.
7. Chalasani N, Clark WS, Martin LG, Kamean J, Khan MA, Patel NH, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118:138-144.